Search

everythinglearnresearchcommunity

for

Search:↓

Scalp reduction gives the most natural result for significant crown baldness, despite potential complications, and a systematic approach to surgical hair restoration results in few complications and high graft survival.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

Alopecia areata can cause unpredictable hair loss, and treatments like corticosteroids and minoxidil may help but have varying side effects.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

The position of the parietal whorl can predict safe donor areas for hair transplants in Korean men with male pattern baldness.

Restoring immune privilege in hair follicles could help treat certain types of hair loss.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

The new hair follicle harvesting technique improves hair transplant results and makes the procedure quicker and easier to learn.

Transplanted whisker follicles caused hair growth on the spine of mice.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Platelet-rich plasma treatment significantly increased hair regrowth and decreased discomfort in alopecia patients, making it a potentially better and safer treatment option.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

Skin grafts on mice can cause an immune response leading to hair loss, useful for studying human hair loss conditions.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Minoxidil and finasteride treat hair loss; more research needed for other options.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Using patients' own fat-derived cells to treat alopecia areata significantly improved hair growth and was safe.

Stem cell therapy may help treat tough hair loss cases.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

Alopecia areata involves immune response and gene changes affecting hair loss.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

Some treatments can help hair regrowth in alopecia areata, but none offer a cure, and effectiveness varies.

Hair thickness decreases from the upper to lower areas of the back of the head, affecting hair transplant results.

Transplanted baby mouse skin cells grew normal hair using a new, efficient method.

The PRP-like cosmetic with biomimetic peptides is potentially effective and safe for treating alopecia areata.

Intralesional triamcinolone acetonide is more effective than platelet-rich plasma for treating scalp alopecia areata.